Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Nature Medicine

Volumn 8, Issue 11, 2002, Pages 1288-1295

  Yamauchi, T ^a,b   Kamon, J ^a   Minokoshi, Y ^c   Ito, Y ^a   Waki, H ^a,b   Uchida, S ^a   Yamashita, S ^a   Noda, M ^b,d   Kita, S ^a   Ueki, K ^a   Eto, K ^a,b   Akanuma, Y ^b,d   Froguel, P ^e   Foufelle, F ^f   Ferre, P ^f   Carling, D ^g   Kimura, S ^a   Nagai, R ^a   Kahn, B B ^c   Kadowaki, T ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

^d INSTITUTE FOR ADULT DISEASES   (Japan)

^e INSTITUT PASTEUR DE LILLE   (France)

^f INSERM   (France)

^g IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LACTIC ACID; PROTEIN KINASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HOMEOSTASIS; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACETYL-COA CARBOXYLASE; ADIPONECTIN; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; FATTY ACIDS; GLUCOSE; HEPATOCYTES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEINS;

ANIMALIA;

EID: 0036851817     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm788     Document Type: Article

References (25)

1. Kahn, B.B. & Flier, J.S. Obesity and insulin resistance. I. Clin. Invest. 106, 473-481 (2000).
2. Shulman, G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171-176 (2000).
3. Arita, Y. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83 (1999).
4. Fruebis, J. et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 98, 2005-2010 (2001).
5. Yamauchi, T. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med. 7, 941-946 (2001).
6. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. & Scherer, P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Med. 7, 947-953 (2001).
7. Combs, T.P., Bergm, A.H., Obici, S., Scherer, P.E. & Rossetti, L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108, 1875-1881 (2001).
8. Abu-Elheiga, L., Matzuk, M.M., Abo-Hashema, K.A. H. & Wakil, S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291, 2613-2616 (2001).
9. Hardie D.G., Carling, D. & Carlson, M. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Ann. Rev. Biochem. 67, 821-855 (1998).
10. Winder, W.W. & Hardie, D.G., AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes. Am. J. Physiol. 277, E1-E10 (1999).
11. Mu, J., Brozinick, J.T. Jr., Valladares, O., Bucan, M. & Birnbaum, M.J. A role for AMP-activated protein kinase in contraction - and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell. 7, 1085-1094 (2000).
12. Lochhead, P.A., Salt, I.P., Walker, K.S., Hardie, D.G. & Sutherland, C. 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49, 896-903 (2000).
13. Stein, S.C., Woods, A., Jones, N.A., Davison, M.D. & Carling, D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 345, 437-443 (2000).
14. Woods, A. et al. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell Biol. 20, 6704-6711 (2000).
15. Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343 (2002).
16. Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174 (2001).
17. Fryer, L.G., Parbu-Patel, A. & Carling, D. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277, 25226-25232 (2002).
18. Tsao, T.S., Murrey, H.E., Hug, C., Lee, D.H. & Lodish, H.F. Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J. Biol. Chem. 277, 29359-29362 (2002).
19. Woods, A., Salt, I., Scott, J., Hardie, D.G. & Carling, D. The α1 and α2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397, 347-3S1 (1996).
20. Hayashi, T. et al. Metabolic stress and altered glucose transport. Activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49, S27-S31 (2000).
21. Kaburagi, Y. et al. Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. J. Biol. Chem. 268, 16610-166222 (1993).
22. Onishi, M. et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18, 3871-3879 (1996).
23. Tontonoz, P., Hu, E. & Spiegelman, B.M. Stimulation of adipogenesis in fibroblasts by PPAR γ2, a lipid-activated protein transcription factor. Cell 79, 1147-1156 (1994).
24. Ueki, K. et al. Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy. J. Clin. Invest. 105, 1437-144S (2000).
25. Tsubamoto, Y. et al. Hexamminecobalt(III) chloride inhibits glucose-induced insulin secretion at the exocytotic process. J. Biol. Chem. 276, 2979-298S (2001).